Atherosclerosis  >>  Jardiance (empagliflozin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Jardiance (empagliflozin) / Eli Lilly, Boehringer Ingelheim
ACTRN12623000661673: Can Semaglutide or empagliflozin stabilise coronary atherosclerosis in people with type 2 diabetes after acute coronary syndrome

Not yet recruiting
2
132
 
South Australian Health and Medical Research Institute, The Hospital Research Foundation
Type 2 diabetes, Coronary atherosclerosis
 
 

Download Options